Bruker Total Non-Cash Items 2010-2024 | BRKR

Bruker annual/quarterly total non-cash items history and growth rate from 2010 to 2024. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
  • Bruker total non-cash items for the quarter ending December 31, 2024 were $0.216B, a 2194.68% increase year-over-year.
  • Bruker total non-cash items for the twelve months ending December 31, 2024 were $0.465B, a 75.65% increase year-over-year.
  • Bruker annual total non-cash items for 2024 were $0.216B, a 2194.68% increase from 2023.
  • Bruker annual total non-cash items for 2023 were $0.009B, a 92.17% decline from 2022.
  • Bruker annual total non-cash items for 2022 were $0.12B, a 5.81% decline from 2021.
Bruker Annual Total Non-Cash Items
(Millions of US $)
2024 $216
2023 $9
2022 $120
2021 $127
2020 $101
2019 $90
2018 $101
2017 $115
2016 $65
2015 $78
2014 $94
2013 $109
2012 $113
2011 $87
2010 $66
2009 $59
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $5.560B $3.366B
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
Stock Name Country Market Cap PE Ratio
Kewaunee Scientific (KEQU) United States $0.106B 7.45
Harvard Bioscience (HBIO) United States $0.016B 0.00